Published in Acta Neuropathol Commun on September 26, 2014
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med (2016) 0.97
In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res (2015) 0.86
Age-related myelin degradation burdens the clearance function of microglia during aging. Nat Neurosci (2016) 0.86
Targeting innate immunity for neurodegenerative disorders of the central nervous system. J Neurochem (2016) 0.85
STIM and ORAI proteins in the nervous system. Channels (Austin) (2015) 0.85
Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun (2015) 0.83
The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer's Disease. Immun Ageing (2014) 0.80
Young microglia restore amyloid plaque clearance of aged microglia. EMBO J (2016) 0.80
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination. Front Cell Neurosci (2015) 0.79
Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice. PLoS One (2015) 0.78
Effects of Moderate Prenatal Alcohol Exposure during Early Gestation in Rats on Inflammation across the Maternal-Fetal-Immune Interface and Later-Life Immune Function in the Offspring. J Neuroimmune Pharmacol (2016) 0.78
Characteristics of spinal microglia in aged and obese mice: potential contributions to impaired sensory behavior. Immun Ageing (2015) 0.77
High-fat diet-induced brain region-specific phenotypic spectrum of CNS resident microglia. Acta Neuropathol (2016) 0.77
Microglial immunophenotype in dementia with Alzheimer's pathology. J Neuroinflammation (2016) 0.76
Significant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model. Sci Rep (2016) 0.76
The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain. PLoS One (2017) 0.76
The role of interleukin-6 in central nervous system demyelination. Neural Regen Res (2016) 0.75
Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System. Int J Mol Sci (2016) 0.75
Reestablishing microglia function: good news for Alzheimer's therapy? EMBO J (2017) 0.75
Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits. J Neurosci (2017) 0.75
In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence. Mol Psychiatry (2017) 0.75
Microglia in Glia-Neuron Co-cultures Exhibit Robust Phagocytic Activity Without Concomitant Inflammation or Cytotoxicity. Cell Mol Neurobiol (2015) 0.75
Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging. Nat Neurosci (2017) 0.75
Absence of CX3CR1 impairs the internalization of Tau by microglia. Mol Neurodegener (2017) 0.75
Repression of telomere-associated genes by microglia activation in neuropsychiatric disease. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Aging: a theory based on free radical and radiation chemistry. J Gerontol (1956) 20.39
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 11.24
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 8.42
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Physiology of microglia. Physiol Rev (2011) 6.99
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol (1990) 6.79
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron (2006) 6.38
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci (2007) 6.23
Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2006) 5.61
The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol (2010) 5.59
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science (1988) 5.56
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res (1998) 4.87
APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29
Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci (1998) 4.19
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci (2008) 3.90
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol (2011) 3.69
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58
Reactive microgliosis. Prog Neurobiol (1999) 3.55
Debris clearance by microglia: an essential link between degeneration and regeneration. Brain (2008) 3.36
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med (2001) 3.32
Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem (2002) 3.14
Microglia as neuroprotective, immunocompetent cells of the CNS. Glia (2002) 3.12
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci (2011) 3.06
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
Microglia: scapegoat, saboteur, or something else? Science (2013) 2.94
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol (2008) 2.86
Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85
Changing face of microglia. Science (2010) 2.79
Functional plasticity of microglia: a review. Glia (1988) 2.76
Primary central nervous system lymphoma. J Neurosurg (1988) 2.75
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol (2002) 2.68
Glial reactions in Parkinson's disease. Mov Disord (2008) 2.62
Microglia: biology and pathology. Acta Neuropathol (2009) 2.51
Microglia: new roles for the synaptic stripper. Neuron (2013) 2.44
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol (2010) 2.31
Microglia derived from aging mice exhibit an altered inflammatory profile. Glia (2007) 2.29
The human side of microglia. Trends Neurosci (2014) 2.27
Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging (1988) 2.24
Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol (2009) 2.09
Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04
Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol (1999) 2.01
Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2005) 1.88
Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol (1996) 1.87
Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol (2013) 1.82
Microglia and Alzheimer's disease pathogenesis. J Neurosci Res (2004) 1.81
Dystrophic microglia in the aging human brain. Glia (2004) 1.79
Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia (2002) 1.79
Bone marrow derived elements and resident microglia in brain inflammation. Glia (1993) 1.78
Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol (2013) 1.77
Progressive dendritic changes in aging human cortex. Exp Neurol (1975) 1.73
Altered antigen expression of microglia in the aged rodent CNS. Glia (1993) 1.68
Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67
Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm (Vienna) (2010) 1.66
Vascular cognitive impairment. Nat Clin Pract Neurol (2006) 1.64
Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging (1998) 1.54
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54
Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion. Acta Neuropathol (1988) 1.52
Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol (2014) 1.52
Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett (1990) 1.51
Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord (2011) 1.51
Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci (1987) 1.50
Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol (1998) 1.49
Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol (1989) 1.49
Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One (2013) 1.48
Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Arch Neurol (2000) 1.47
Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci Lett (2003) 1.46
Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res (1997) 1.46
Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2010) 1.45
Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol (2010) 1.45
Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (1990) 1.43
The Neuropathology of HIV/AIDS. Int Rev Psychiatry (2008) 1.41
Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol (1974) 1.41
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J Neuroinflammation (2005) 1.41
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia (2007) 1.40
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol (1990) 1.40
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (1995) 1.40
The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci (1989) 1.38
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology (2008) 1.36
Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res (2007) 1.35
Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol (1997) 1.31
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci (2009) 1.31
Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29
Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport (1994) 1.29
Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (1998) 1.29
Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int (2012) 1.29
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging (2014) 1.28
Comprehensive characterization and failure modes of tungsten microwire arrays in chronic neural implants. J Neural Eng (2012) 1.27
Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect (1990) 1.27
Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J (2002) 3.81
Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci (2004) 3.17
What is immune privilege (not)? Trends Immunol (2006) 3.02
TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain (2006) 2.80
Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med (2006) 2.72
Sickle hemoglobin confers tolerance to Plasmodium infection. Cell (2011) 2.67
Microglia: biology and pathology. Acta Neuropathol (2009) 2.51
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol (2009) 2.09
Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J (2005) 2.04
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron (2005) 2.01
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia (2008) 1.97
The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry (2011) 1.96
Migration of monocytes after intracerebral injection at entorhinal cortex lesion site. J Leukoc Biol (2012) 1.93
Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J (2009) 1.82
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol (2006) 1.76
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med (Berl) (2006) 1.73
Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci (2013) 1.62
Microglia in the aging brain. J Neuropathol Exp Neurol (2006) 1.60
CNS pericytes: concepts, misconceptions, and a way out. Glia (2010) 1.59
CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci (2004) 1.57
Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol (2009) 1.57
Life and death of microglia. J Neuroimmune Pharmacol (2009) 1.54
Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol (2008) 1.52
Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet (2013) 1.48
Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2010) 1.45
Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol (2010) 1.44
Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res (2007) 1.35
Perivascular spaces--MRI marker of inflammatory activity in the brain? Brain (2008) 1.33
Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest (2005) 1.32
IDO expression in the brain: a double-edged sword. J Mol Med (Berl) (2007) 1.30
T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol (2006) 1.30
Comprehensive characterization and failure modes of tungsten microwire arrays in chronic neural implants. J Neural Eng (2012) 1.27
The effects of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol (2007) 1.26
CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol (2010) 1.21
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia (2008) 1.21
Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J Neuroinflammation (2007) 1.21
Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One (2013) 1.20
Comparison of modified Thiel embalming and ethanol-glycerin fixation in an anatomy environment: Potentials and limitations of two complementary techniques. Anat Sci Educ (2014) 1.16
Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology (2005) 1.15
Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci (2012) 1.15
The repulsive guidance molecule RGMa is involved in the formation of afferent connections in the dentate gyrus. J Neurosci (2004) 1.15
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) (2008) 1.14
Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia (2010) 1.13
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci (2002) 1.09
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia (2008) 1.08
R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One (2010) 1.08
Pneumolysin causes neuronal cell death through mitochondrial damage. Infect Immun (2007) 1.07
Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene. J Neuroimmunol (2006) 1.07
NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol Dis (2010) 1.05
Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia (2004) 1.05
Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia (2013) 1.05
Telomeres shorten with age in rat cerebellum and cortex in vivo. J Anti Aging Med (2003) 1.04
Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog Neurobiol (2008) 1.02
TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol (2002) 1.01
High calorie diet triggers hypothalamic angiopathy. Mol Metab (2012) 1.01
The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol (2013) 1.01
The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am J Reprod Immunol (2010) 0.99
The Brain's Aging Immune System. Aging Dis (2010) 0.98
The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene. J Neurosci Res (2005) 0.98
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro Oncol (2013) 0.98
Effect of aging on the microglial response to peripheral nerve injury. Neurobiol Aging (2005) 0.97
Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold. Biochem Pharmacol (2002) 0.97
CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J Neuroimmunol (2008) 0.97
TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. J Immunol (2007) 0.97
Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production. J Neuroinflammation (2007) 0.96
IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. Adv Exp Med Biol (2003) 0.96
Neuroprotection by T-cells depends on their subtype and activation state. J Neuroimmunol (2002) 0.96
Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. J Neurosci (2003) 0.96
IL-2 gene knockout affects T lymphocyte trafficking and the microglial response to regenerating facial motor neurons. J Neuroimmunol (2003) 0.95
Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Brain Pathol (2014) 0.94
Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J Neurochem (2008) 0.94
Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection. J Immunol (2012) 0.93
Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J Mol Med (Berl) (2004) 0.90
Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J (2003) 0.89
Minocycline does not inhibit microglia proliferation or neuronal regeneration in the facial nucleus following crush injury. Neurosci Lett (2005) 0.87
Chondroitinase applied to peripheral nerve repair averts retrograde axonal regeneration. Exp Neurol (2006) 0.87
Entorhinal cortex lesion in the mouse induces transsynaptic death of perforant path target neurons. Brain Pathol (2004) 0.87
Host strategies against virus entry via the olfactory system. Virulence (2011) 0.86
Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo. Neoplasia (2008) 0.86
Alzheimer's disease, neuroprotection, and CNS immunosenescence. Front Pharmacol (2012) 0.86
Altered microglial phagocytosis in GPR34-deficient mice. Glia (2014) 0.86
PD-L1 (B7-H1) regulation in zones of axonal degeneration. Neurosci Lett (2007) 0.85
A preclinical assessment of neural stem cells as delivery vehicles for anti-amyloid therapeutics. PLoS One (2012) 0.84
In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system. Methods (2003) 0.84
Structural reorganization of the dentate gyrus following entorhinal denervation: species differences between rat and mouse. Prog Brain Res (2007) 0.84
Effects of axotomy on telomere length, telomerase activity, and protein in activated microglia. J Neurosci Res (2005) 0.83
T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease. Proc Natl Acad Sci U S A (2012) 0.83
Axonally transported peripheral signals regulate alpha-internexin expression in regenerating motoneurons. J Neurosci (2002) 0.83
Microglial pathology in Down syndrome. Acta Neuropathol (2011) 0.82
Ectoderm removal prevents cutaneous nerve formation and perturbs sensory axon growth in the chick hindlimb. Dev Biol (2004) 0.82
Electrode failure: tissue, electrical, and material responses. IEEE Pulse (2012) 0.82
CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia (2014) 0.82
Inflammatory response after neurosurgery. Best Pract Res Clin Anaesthesiol (2004) 0.81
Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes. J Neurooncol (2006) 0.81
Microglial senescence. CNS Neurol Disord Drug Targets (2013) 0.81